Compare ROIV & NMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROIV | NMR |
|---|---|---|
| Founded | 2014 | 1925 |
| Country | United Kingdom | Japan |
| Employees | N/A | 27242 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 22.8B |
| IPO Year | 2021 | N/A |
| Metric | ROIV | NMR |
|---|---|---|
| Price | $28.38 | $8.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $28.94 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 1.8M |
| Earning Date | 05-28-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $6.00 |
| Revenue Next Year | $744.61 | $4.76 |
| P/E Ratio | ★ N/A | $12.03 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.58 | $5.48 |
| 52 Week High | $30.33 | $9.58 |
| Indicator | ROIV | NMR |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 47.65 |
| Support Level | $26.94 | $8.04 |
| Resistance Level | $30.26 | $8.50 |
| Average True Range (ATR) | 0.88 | 0.15 |
| MACD | -0.16 | -0.06 |
| Stochastic Oscillator | 43.27 | 33.97 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking, which is engaged in advisory, financing, and solutions businesses.